Loading...
A View from Congress: Role of Pharmacy Benefit Managers in Pharmaceutical Markets
House Committee on Oversight and Reform
House Committee on Oversight and Reform
Abstract
The Committee on Oversight and Reform examines the issue of rising prescription drug costs in the United States, emphasizing the role of Pharmacy Benefit Managers (PBMs) in the marketplace. The report states that while Democrats have focused on attacking pharmaceutical companies, there's a need to examine the practices of PBMs, which act as intermediaries in negotiating drug costs. The report highlights the rise in drug prices and patient out-of-pocket costs, particularly over the past decade coinciding with PBM market consolidation. The report outlines twenty-two legislative solutions aimed at reforming the pharmaceutical market and reducing drug costs for Americans.
Date
2021-12-10
Document Type
House Minority Staff Report
Serial Number
Document Length
19 pages
Congress
117
Relation
DOI
Keywords
Staff Reports
PAP Major Code
3: Health
PAP Minor Code
335: Prescription Drug Coverage and Costs
Related Hearings
Press Releases and Contextual Information
https://web.archive.org/web/20230614234338/https://oversight.house.gov/report/comer-releases-report-on-pbms-tactics-leading-to-soaring-prescription-drug-prices/